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Calpain Inhibition Attenuates 
Adipose Tissue Inflammation and 
Fibrosis in Diet-induced Obese Mice
Latha Muniappan1, Aida Javidan1, Weihua Jiang1, Shayan Mohammadmoradi  1, Jessica J. 
Moorleghen1, Wendy S. Katz1, Anju Balakrishnan1, Deborah A. Howatt1 & Venkateswaran 
Subramanian1,2
Adipose tissue macrophages have been proposed as a link between obesity and insulin resistance. 
However, the mechanisms underlying these processes are not completely defined. Calpains are calcium-
dependent neutral cysteine proteases that modulate cellular function and have been implicated in 
various inflammatory diseases. To define whether activated calpains influence diet-induced obesity 
and adipose tissue macrophage accumulation, mice that were either wild type (WT) or overexpressing 
calpastatin (CAST Tg), the endogenous inhibitor of calpains were fed with high (60% kcal) fat diet for 
16 weeks. CAST overexpression did not influence high fat diet-induced body weight and fat mass gain 
throughout the study. Calpain inhibition showed a transient improvement in glucose tolerance at 5 
weeks of HFD whereas it lost this effect on glucose and insulin tolerance at 16 weeks HFD in obese mice. 
However, CAST overexpression significantly reduced adipocyte apoptosis, adipose tissue collagen and 
macrophage accumulation as detected by TUNEL, Picro Sirius and F4/80 immunostaining, respectively. 
CAST overexpression significantly attenuated obesity-induced inflammatory responses in adipose 
tissue. Furthermore, calpain inhibition suppressed macrophage migration to adipose tissue in vitro. 
The present study demonstrates a pivotal role for calpains in mediating HFD-induced adipose tissue 
remodeling by influencing multiple functions including apoptosis, fibrosis and inflammation.
Accumulation of adipose tissue macrophages has been proposed as a major link between obesity, insulin resist-
ance and type 2 diabetes1. However, the mechanisms underlying these processes are still remain elusive. Calpains 
are calcium dependent intracellular cysteine proteases that tightly regulate their substrate proteins through 
limited proteolysis2. The two major isoforms, calpain-1 and -2, are expressed ubiquitously, whereas the other 
isoforms (e.g. -3, -9) are tissue-specific2. Activated calpain by calcium damages cells by selectively degrading 
intracellular proteins, including signaling proteins (e.g., cyclin-dependent kinase, protein kinase C)3,4, cytoskel-
etal proteins (e.g., talin, spectrin)5,6, and transcription factors (e.g., c-Jun, IkB)7–9. Calpains play a critical role 
in cellular apoptosis through activation of both caspase-dependent and caspase-independent pathways10,11. 
Calpains are also involved in acute inflammatory processes via the activation of nuclear factor kappa B (NF-kB)12. 
Since calcium-induced calpain activation is an irreversible reaction, calpains are tightly regulated by calpastatin 
(CAST), which is an endogenous inhibitor that binds strongly to calpains13. CAST contains four tandem repeats 
of a calpain-inhibitory domain, and each CAST molecule is capable of inhibiting more than one calpain mole-
cule14. Calpains have been implicated to play a critical deleterious role in endothelial dysfunction15, hypertrophy 
and fibrosis16, and intestinal macrophage activation in experimental colitis17.
Recently, using a pharmacological inhibitor and calpain-1 deficient mice, we demonstrated that calpain inhi-
bition significantly attenuated inflammatory processes present in aortic vascular diseases such as angiotensin 
II (AngII)-induced abdominal aortic aneurysms (AAA) and atherosclerosis in mice18,19. The beneficial effect of 
calpain inhibition was associated with reduction of macrophage accumulation, NF-kB mediated inflammation, 
and cytoskeletal protein, filamin A, fragmentation in the aorta19. However, the functional contributions of calpain 
activation in chronic adipose tissue inflammation, and macrophage infiltration under the condition of obesity 
remains to be elucidated.
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Using CAST transgenic mice, we demonstrate that calpain inhibition transiently improved glucose tolerance 
and resulted in decreased adipose tissue macrophage accumulation in obese mice. Furthermore, calpain inhibi-
tion significantly modulated adipose tissue remodeling by influencing multiple functions including adipocyte 
apoptosis, fibrosis, inflammation and migratory properties of macrophages.
Results
Calpain Protein and Activity Are Increased in Adipose Tissue of Obese Mice. To determine 
whether obesity increases calpain protein and activity in adipose tissue, we harvested protein from adipose tissue 
of C57BL/6 mice fed a low fat diet (LFD; 10% Kcal) or high fat diet (HFD; 60% Kcal) for 16 weeks. Western blot 
analyses using antibodies against calpains showed that protein abundance of calpain-1 was slightly increased 
whereas the protein abundance of calpain-2 and calpain-4 (the common small subunit of both calpain-1 and -2) 
were highly increased in epididymal white adipose tissue (EpiWAT) from HFD fed obese mice compared to LFD 
fed lean mice (Fig. 1A). In addition, protein abundance of CAST was decreased in WAT from HFD fed obese mice 
(Fig. 1A). Furthermore, immunohistochemical staining of adipose tissue also confirmed increased calpain-2 pro-
tein in HFD mice compared to LFD lean mice (Fig. 1B). HFD-induced obesity resulted in a ~2.0 -fold increase in 
total calpain activity, as demonstrated by increased breakdown of fluorescent-labeled calpain substrate, Ac-LLY-
AFC, in visceral adipose tissue (Fig. 1C). To delineate the cell type expressing calpain in adipose tissue, mature 
adipocytes and stromal vascular fractions (SVF) were harvested from adipose tissue of C57BL/6 mice. Western 
blot analyses using protein harvested from mature adipocytes and SVF-derived cells showed that calpain proteins 
are strongly expressed in both mature adipocytes and SVF (Fig. 1D).
CAST Overexpression Had No Effect on Diet-induced Body Weight Gain and Fat Mass. To investigate 
the role of calpains in diet-induced obesity, we used CAST overexpressing transgenic mice to inhibit activities 
of both calpain-1 and -2. We confirmed presence of the CAST transgene (CAST-Tg) by PCR using tail DNA 
(Figure S1 in the online-only Data Supplement). Western blot analyses showed a modest ~ 2 fold increase in the 
abundance of CAST protein in EpiWAT (Fig. 1E) and bone marrow-derived macrophages (BMDM; Fig. 1F) of 
CAST-Tg mice compared to WT mice. This data confirms transgenic overexpression of CAST in different tissues.
To examine the role of calpains in diet induced obesity, male WT or CAST-Tg mice were fed with LFD or HFD 
for 16 weeks. HFD feeding resulted in a 2.2-fold increase in calpain activity, as demonstrated by increased break-
down of fluorescent-labeled calpain substrate, Ac-LLY-AFC, in EpiWAT harvested from WT mice, whereas CAST 
overexpression significantly attenuated HFD-induced calpain activity in EpiWAT (Fig. 1G). This data clearly 
suggests a strong inhibition of calpain activity in WAT by CAST overexpression.
HFD feeding significantly increased body weight in both WT and Tg groups of mice compared to LFD groups. 
However, CAST overexpression did not affect diet-induced body weight gain (Fig. 1H). To examine whether there 
are differences in body fat mass (Fig. 1I) and lean mass (Fig. 1J), we analyzed body composition before and after 
feeding HFD. Fat and lean mass were significantly increased in HFD mice of both WT and Tg groups compared 
with LFD controls, with no significant differences between genotypes. The mass of liver, epididymal, retroperi-
toneal, subcutaneous and brown adipose tissues were increased significantly in HFD fed mice of each genotype 
compared with LFD-fed controls, with no significant differences between the genotypes (Table 1). HFD feeding 
or CAST overexpression had no effect on blood cell counts (Table 1). CAST overexpression had no effect on food 
and water intake (Supplementary Table 1). HFD feeding increased adipocyte size in tissue sections from mice of 
each genotype. Quantification of adipocyte size demonstrated that there is no significant difference in adipocyte 
size distribution between the genotypes (Figure SII in the online-only Data Supplement). Therefore, CAST over-
expression had no effect on the development of diet-induced obesity in mice fed HFD.
CAST Overexpression Improved Glucose Tolerance in Early but not Late Stages of Obesity. To 
examine the effect of CAST overexpression on HFD-induced glucose tolerance, we performed glucose tolerance 
test (GTT) and insulin tolerance test (ITT) during an early (5 or 6 weeks post diet) and late (15 or 16 weeks post 
diet) stage of obesity. After 5 weeks of diet consumption, CAST Tg mice showed a dramatic improvement in 
glucose tolerance in both LFD and HFD groups (Fig. 2A,B) compared to the WT group (P < 0.05). While after 15 
weeks of diet consumption, the CAST Tg HFD group showed no difference compared to the WT group; however 
the CAST Tg LFD group showed significant improvement compared to WT-LFD group (P < 0.05; Fig. 2C,D). 
With respect to ITT, HFD feeding significantly impaired insulin tolerance tests in both genotypes. However, 
CAST Tg mice showed a very modest improvement in ITT compared to WT group (Fig. 2E–H). Plasma insulin 
and leptin concentrations were increased significantly by HFD feeding in both genotype groups of mice (Figure 
SIII in the online-only Data Supplement). However, CAST Tg mice had a significant increase in plasma insulin 
concentration compared to WT-HFD group (Figure SIIIA,B). Irrespective of increased insulin concentration, 
CAST Tg mice showed no significant improvement on GTT. Furthermore, Western blot analyses of adipose tis-
sue from either 5 or 16 weeks LFD and HFD mice showed no alterations in protein abundance of calpain-10, an 
atypical calpain associated with insulin resistance in diabetic populations20,21 (Figure SIIIE,F in the online-only 
Data Supplement).
CAST Overexpression Suppressed High Fat Diet-induced Adipocyte Cell Death. Calpains play 
a critical role in calcium mediated cell apoptosis in association with caspase-3 pathway in various cell types22,23. 
Obesity is associated with increased adipocyte death, which in turn triggers macrophage accumulation for the 
removal of cell debris by phagocytosis24,25. To examine whether CAST overexpression had any influence on 
HFD-induced adipocyte cell death, we performed TUNEL staining on EpiWAT from 5 and 16 weeks LFD and 
HFD-fed groups of mice26,27. TUNEL staining showed very few TUNEL-positive (apoptotic) cells at 5 weeks of 
HFD feeding which is not statistically significant compared to LFD group (Figure SIV in the online-only Data 
www.nature.com/scientificreports/
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Figure 1. Abundance of calpain protein and its activity was increased in obese adipose tissue. (A) Calpain-1, -2, 
-4, CAST and β-actin protein were detected by Western blotting in epididymal white adipose tissue (EpiWAT) 
extracts of wild type mice fed either a LFD or HFD for 16 weeks (n = 3). (B) Cross-sections from the EpiWAT of 
LFD and HFD fed wild type mice were immunostained with anti-mouse calpain-2 (red color). Arrows indicate 
positive immunostaining. (C) Calpain activity was measured by fluorimetric assay in EpiWAT from LFD and 
HFD fed mice (n = 4). (D) Calpain-1, -2 and -4 protein were detected by Western blotting in matured adipocyte 
and SVF cells. CAST protein was detected in EpiWAT (E) and BMDM. (F) Representative Western blot 
images are cropped from the full-length blot. The full-length Western blots are included in the Supplementary 
information. (G) Calpain activity was measured by fluorimetric assay in EpiWAT from LFD and HFD fed WT 
and CAST Tg mice (n = 4). (H) Body weight of LFD and HFD fed male WT and CAST Tg mice (n = 13–15). 
Body fat mass (I) and lean mass (J) of LFD and HFD fed male WT and CAST Tg mice (n = 12–14). *And 
horizontal lines represent significance of P < 0.05 (Two-way ANOVA with Holm-Sidak post hoc analysis).
www.nature.com/scientificreports/
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Supplement). HFD feeding to mice for 16 weeks showed a significantly increased number of TUNEL-positive 
cells compared to LFD group (P < 0.05; Fig. 3A).
Compared to the WT group, CAST Tg overexpression showed significantly less number of TUNEL + cells 
(P < 0.05; Fig. 3A). Furthermore, immunostaining using an antibody against cleaved caspase-3, a marker of apop-
tosis26, showed increased staining in adipose tissue from WT mice, not in CAST Tg mice fed HFD (Fig. 3B). In 
addition, a fluorescent based caspase-3 activity assay also revealed a significant suppression of HFD-induced 
caspase-3 activity in CAST Tg mice compared to WT-HFD mice (P < 0.05; Fig. 3C). Furthermore, mRNA abun-
dance of pro-apoptotic genes (e.g. Bax, BCL10) in adipose tissue were significantly increased at 16 week (Fig. 3D), 
but not in 5 week (Figure SIV in the online-only Data Supplement) HFD fed WT mice. In contrast, CAST over-
expression significantly suppressed pro-apoptotic gene expression (P < 0.05; Fig. 3D) in 16 week HFD fed mice.
CAST Overexpression Suppressed Adipose Tissue Macrophage Accumulation in Obese Mice. 
Since adipocyte apoptosis has been implied as one of the key events that contributes to adipose tissue macrophage 
infiltration25, we examined the contribution of calpains on macrophage accumulation during HFD-induced obe-
sity. Immunofluorescent staining using an anti-F4/80 antibody revealed accumulation of F4/80 + macrophages in 
5 and 16 weeks HFD-induced obese adipose tissue (Figure SV in the online-only Data Supplement and Fig. 4A). 
Compared to WT, CAST Tg overexpression had significantly less macrophage recruitment (Figure SVA and 4 A). 
Consistently, mRNA abundance of macrophage markers (F4/80, CD68, CD11C, CD206), monocyte chemoat-
tractant protein-1 (MCP-1) and its cognate receptor, CCR2 were significantly increased in obese adipose tis-
sue (Figure SVB and Fig. 4B) in HFD fed WT mice. In contrast, CAST Tg overexpression significantly reduced 
macrophage marker genes, but had no effect on MCP-1 and CCR2 (Fig. 4B). Since CAST overexpression had 
no effect on MCP-1 and CCR2 mRNA abundance, we examined whether CAST overexpression had any effect 
on MCP-1 secretion from adipose tissue. EpiWAT explants from WT and CAST Tg mice were incubated with 
adipogenic cocktail for 24 h28. Adipogenic cocktail incubation significantly increased MCP-1 concentrations in 
cultured media of adipose explants from both WT and CAST Tg mice (Fig. 4C). To define potential mecha-
nisms by which CAST overexpression influenced macrophage accumulation in adipose tissue, we investigated 
whether CAST overexpression influenced functional properties of macrophages such as migration. Using bone 
marrow-derived macrophages (BMDMs) harvested from WT and CAST Tg mice, we examined the effect of 
CAST overexpression on macrophage migration towards monocyte chemoattractant, MCP-1, using an in vitro 
transwell migration assay29. MCP-1 strongly stimulated migration of macrophages from WT mice compared to 
vehicle control, whereas overexpression of CAST significantly reduced MCP-1-induced macrophage migration 
(Fig. 4D–H). These data suggest that calpain inhibition in macrophages by CAST overexpression decreased the 
migration abilities of macrophages towards adipose tissue.
CAST Overexpression Attenuated HFD-induced Inflammation. To further investigate the role of 
calpain on HFD-induced adipose tissue inflammation, mRNA abundance of inflammatory cytokines such as 
TNFα, IL-6, IL-1β, IL-10) were examined in EpiWAT tissue. HFD-induced obesity significantly increased mRNA 
abundance of TNFα and IL-6 in both 5 (Figure SVC in the online-only Data Supplement) and 16 week points, 
IL-1β at 16 weeks (Fig. 5A), and had no effect on IL-10 (Fig. 5A). In contrast, CAST overexpression significantly 
reduced HFD-induced TNFα, IL-6 and IL-1β gene expression (Figure SVC and Fig. 5A).
IKK-dependent NF-kB activation has been implicated in the development of obesity30. Activated NF-kB is 
also shown to induce inflammatory cytokines such as IL-6 and TNF-α31. NF-kB is sequestered in the cytosol and 
its translocation to the nucleus is prevented by the inhibitor of NF-kB translocation (IkB)32. IκB was also shown 
to be a target of calpain in selected cell types including macrophages17,33,34. In order to investigate the possibility 
that calpain activation mediates obesity-induced NF-kB activation, we used 3T3-L1 adipocytes as a model sys-
tem. Undifferentiated and differentiated 3T3-L1 adipocytes were transfected with control or calpain-4 (common 
small subunit of calpain-1 and -2) siRNA for 48 h. The cells were then stimulated with lipopolysaccharide (LPS) 
for 24 h. Protein was extracted from the cells and subjected to Western blot analyses. Transfection of cells with 
calpain-4 siRNA strongly suppressed calpain-1 and -2 protein as evidenced by Western blot analyses (Fig. 5B). 
To delineate whether calpain-4 silencing influences adipogenesis, Oil red O staining was performed on siRNA 
transfected cells. Oil red O staining showed that calpain-4 silencing had no effect on adipocyte differentiation 
Groups CAST WT CAST Tg
Diet LFD HFD LFD HFD
N 10 12 10 13
Liver Weight (g) 1.4 ± 0.06 2.8 ± 0.14* 1.3 ± 0.05 2.3 ± 0.16*
Epididymal Adipose (g) 1.0 ± 0.13 1.7 ± 0.09* 0.96 ± 0.06 1.5 ± 0.07*
Retroperitoneal Adipose (g) 0.3 ± 0.04 1.0 ± 0.03* 0.5 ± 0.04 1.2 ± 0.06*
Sub-cutaneous Adipose (g) 0.4 ± 0.05 2.4 ± 0.11* 0.4 ± 0.03 2.0 ± 0.12*
Brown Adipose (g) 0.3 ± 0.02 0.5 ± 0.03* 0.3 ± 0.02 0.4 ± 0.02*
RBC (106/µl) 8.8 ± 0.5 11.7 ± 0.1 8.6 ± 0.5 10.5 ± 0.5
Platelets (103/µl) 617 ± 29 514 ± 19 691 ± 49 587 ± 39
Table 1. Effects of calpastatin overexpression on liver, fat pad weight, and blood counts in LFD and HFD fed 
mice. Values are represented as means ± SEMs. *Denotes P < 0.05 when comparing LFD vs HFD, by two-way 
ANOVA.
www.nature.com/scientificreports/
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(Fig. 5C). Furthermore, qPCR analyses showed comparable mRNA abundance of adipogenic genes such as 
PPARγ, CEPBα, CEBPβ, PREF-1 and adiponectin (Fig. 5D). NF-kB activation and IkB degradation were assessed 
by examining the phosphorylation of NF-kB subunit P65, and IkB protein by Western blot. LPS stimulation sig-
nificantly reduced IkB protein and significantly increased phosphorylation of P65 in control siRNA transfected 
cells (Fig. 5E). In contrast, silencing of calpain-1 and -2 significantly prevented LPS-induced IkB protein degra-
dation and P65 phosphorylation in differentiated adipocytes (Fig. 5E).
Figure 2. CAST overexpression improved glucose tolerance in the early stage of obesity. Glucose tolerance 
test (GTT) and the area under curve (AUC) of GTT at week 5 (A,B) and week 15 (C,D) post LFD and HFD in 
CAST WT and Tg mice. Insulin tolerance test (ITT) and the AUC of ITT at week 6 (E,F) and week 16 (G,H) 
post LFD and HFD in CAST WT and Tg mice (n = 12–14). *Denotes P < 0.05 HFD vs LFD; #P < 0.05 CAST 
WT vs CAST Tg (Two-way ANOVA with Holm-Sidak post hoc analysis).
www.nature.com/scientificreports/
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CAST Overexpression Suppressed HFD-induced Adipose Tissue Fibrosis. Recently, excessive 
amounts of extracellular matrix and fibrosis in white adipose tissue have been described in obese individuals35. 
Increased WAT fibrosis is believed to accelerate adipose tissue dysfunction36. In order to understand the effect 
of CAST overexpression on WAT fibrosis, we performed picro-sirius red staining on EpiWAT sections from 5 
Figure 3. CAST overexpression significantly suppressed obesity-induced adipocyte cell death. (A) 
Representative TUNEL staining of EpiWAT cross-sections from 16 week LFD and HFD fed CAST WT and 
Tg mice. The nuclei were stained with DAPI (blue) and the TUNEL-positive cells (red) are indicated by 
arrows. Under fluorescent microscopy, TUNEL-positive cells were counted from 10 fields at the power of 
100x magnification (n = 5). (B) Representative EpiWAT sections from LFD and HFD fed CAST WT and Tg 
mice immunostained for active caspase 3. Arrows indicate positive staining (red). (C) Caspase-3 activity was 
measured by fluorimetric assay in EpiWAT from LFD and HFD fed mice (n = 4). (D) mRNA abundance of Bid, 
Bax, Bcl 10 and Herpud genes in EpiWAT from LFD and HFD fed CAST WT and Tg mice were analyzed by 
qPCR (n = 4–6). Values are represented as mean ± SEM. *and # denotes P < 0.05 when comparing LFD vs HFD 
and WT vs Tg respectively (Two-way ANOVA with Holm-Sidak post hoc analysis).
www.nature.com/scientificreports/
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Figure 4. CAST overexpression significantly reduced macrophage accumulation. (A) Representative 
immunofluorescent staining of F4/80 in EpiWAT cross-sections from 16 week LFD and HFD fed CAST WT 
and Tg mice. The nuclei were stained with DAPI (blue) and the F4/80-positive cells (red) are indicated by 
arrows. Using fluorescent microscopy, F4/80-positive cells were counted from 10 fields at the power of 100x 
magnification (n = 5). (B) mRNA abundance of F4/80, CD68, CD11c, CD206, MCP-1 and CCR2 genes in 
EpiWAT from LFD and HFD fed CAST WT and Tg mice were analyzed by qPCR (n = 5). (C) MCP-1 protein 
accumulation in adipose tissue explant culture media was measured by ELISA. (D-G) WT and CAST-Tg 
BMDMs were seeded on transwell filters and lower chambers were filled with media containing either vehicle 
or MCP-1 (100 µg/mL). Cells that migrated through the membrane stained with hematoxylin and were counted 
from 9 fields at the power of 200x magnification (H) (n = 4). Values are represented as mean ± SEM. *and # 
denotes P < 0.05 when comparing LFD vs HFD and WT vs Tg respectively (Two-way ANOVA with Holm-
Sidak post hoc analysis).
www.nature.com/scientificreports/
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week (Figure SVI in the online-only Data Supplement) and 16 week (Fig. 6A) LFD and HFD fed mice. HFD 
feeding for 16 weeks but not 5 weeks increased adipose tissue fibrosis compared to the LFD group. In contrast, 
CAST overexpression dramatically suppressed collagen deposition in the WAT tissue compared to WT group 
of mice (Fig. 6A). Furthermore, qPCR analyses of WAT mRNA showed that CAST overexpression significantly 
suppressed HFD-induced collagen genes (I, III, V and VI) compared to WT group (Fig. 6B).
Figure 5. CAST overexpression or calpain-4 silencing significantly reduced inflammatory genes in EpiWAT 
tissue or cultured differentiated adipocytes. A. mRNA abundance of TNFα, IL-6, IL-1β, and IL-10 genes in 
EpiWAT from LFD and HFD fed CAST WT and Tg mice were analyzed by qPCR (n = 5). (B) Western blot 
analyses of Calpain-1, -2, -4 and β-actin proteins in control or calpain-4 siRNA transfected differentiated 3T3L1 
adipocytes. (C) Oil red O staining of control or calpain-4 siRNA transfected differentiated 3T3L1 adipocytes. D. 
mRNA abundance of PPARγ, adiponectin, CEBPα, CEBPβ, PREF-1 and UCP-1 genes in control or calpain-4 
siRNA transfected differentiated 3T3L1 adipocytes were analyzed by qPCR (n = 5). (E) Western blot analyses 
of phospho and total P65, IkBα and β-actin proteins in control or calpain-4 siRNA transfected differentiated 
3T3L1 adipocytes incubated with vehicle or LPS (100ng/ml for 24 h; n = 4). Representative Western blot 
images are cropped from the full-length blot. The full-length Western blots are included in the Supplementary 
information. Values are represented as mean ± SEM. *and # denotes P < 0.05 when comparing LFD vs HFD and 
WT vs Tg respectively (Two-way ANOVA with Holm-Sidak post hoc analysis).
www.nature.com/scientificreports/
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CAST Overexpression Had no Effect on HFD-induced Liver Steatosis. Since CAST overexpression 
suppressed HFD-induced adipose tissue inflammation, macrophage accumulation and apoptosis without influ-
encing glucose clearance, next we examined whether CAST overexpression had any effect on other metabolic 
organs such as liver and heart in HFD-induced obese mice. Histological analyses showed similar lipid deposition 
in liver tissue from both WT and CAST Tg mice fed with HFD diet compared to LFD fed mice (Fig. 7A). In addi-
tion, qPCR analyses of selected genes using mRNA from liver and heart tissue showed comparable alterations in 
both CAST WT and Tg groups (Fig. 7B,C). HFD feeding significantly increased fatty acid synthase (FAS) gene 
expression whereas it had no significant effect on fatty acid binding protein (FABP), lipid transporters (ABCA1, 
ABCG1) in liver. CAST Tg overexpression had no effect on HFD-induced FAS in liver (Fig. 7B). In heart tissue, 
HFD feeding significantly suppressed FABP and ABCG1, whereas CAST Tg overexpression had no effect on these 
HFD-induced gene alterations (Fig. 7C). With respect to inflammation, CAST Tg overexpression significantly 
suppressed HFD-induced TNFα gene expression in liver (Fig. 7B).
CAST Overexpression Transiently Suppressed Phosphoenolpyruvate Carboxykinase 1 
(PCK-1) Gene Expression in Liver and Heart Tissue of HFD Fed Obese Mice. qPCR analyses of 
liver and heart tissue showed that HFD feeding for 16 weeks had no effect on glucose metabolic genes such 
as glucose-6-phosphatase (G6P) and phosphoenolpyruvate carboxykinase 1 (PCK-1). Interestingly, CAST Tg 
overexpression showed a significant reduction on PCK-1 mRNA abundance in LFD fed mice compared to WT 
(Fig. 7B, C). Suppression of PCK-1 in liver is shown to promote insulin sensitivity in obese mice37. Coinciding 
with these observations, the glucose tolerance test studies also showed a significant improvement on glucose 
clearance at 16 weeks in LFD fed CAST Tg mice compared to other groups (Fig. 2C). In addition, overexpression 
Figure 6. CAST overexpression reduced interstitial fibrosis in adipose tissue. (A) Representative Sirius red 
staining of EpiWAT cross-sections from LFD and HFD fed CAST WT and Tg mice. (B) mRNA abundance of 
Col I, Col III, Col IV, Col V and Col VI genes in EpiWAT from LFD and HFD fed CAST WT and Tg mice were 
analyzed by qPCR (n = 5). Values are represented as mean ± SEM. *and # denotes P < 0.05 when comparing 
LFD vs HFD and WT vs Tg respectively (Two-way ANOVA with Holm-Sidak post hoc analysis).
www.nature.com/scientificreports/
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of PCK-1 in adipose tissue is shown to cause insulin resistance in HFD fed mice38. However, qPCR analyses of 
adipose tissue revealed that CAST Tg overexpression had no influence on adipose PCK-1 (Figure SVII in the 
online-only Data Supplement). Since CAST Tg overexpression showed a transient improvement in glucose clear-
ance (5 weeks post HFD), next we tested the effect of CAST Tg overexpression on PCK-1 in adipose (Figure SVII 
Figure 7. CAST overexpression had no effect on obesity-induced hepatic steatosis. (A) Representative 
hematoxylin and eosin staining of liver cross-sections from LFD and HFD fed CAST WT and Tg mice. mRNA 
abundance of ABCA1, ABCG1, FAS, FABP, G6P, PCK-1, TNF-α and IL-6 genes in liver (B) and heart (C) from 
16 weeks LFD and HFD fed CAST WT and Tg mice, and PCK-1 gene in liver (D) from 5 week LFD and HFD 
fed CAST WT and Tg mice were analyzed by qPCR (n = 5). Values are represented as mean ± SEM. *and # 
denotes P < 0.05 when comparing LFD vs HFD and WT vs Tg respectively (Two-way ANOVA with Holm-
Sidak post hoc analysis).
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in the online-only Data Supplement) and liver (Fig. 7D) tissue from 5 weeks LFD and HFD mice by qPCR. CAST 
Tg overexpression had no effect on adipose PCK-1 mRNA (SVIIB), whereas it showed a strong suppression of 
liver PCK-1 in both LFD and HFD group compared to WT controls (Fig. 7D).
Discussion
During the course of obesity, adipose tissue undergoes extensive remodeling including adipocyte hypertrophy, 
apoptosis, macrophage infiltration and accumulation, and fibrosis. Using CAST transgenic mice, we examined 
the role of calpains in adipose tissue remodeling during diet induced-obesity. Here we demonstrate that calpain 
inhibition resulted in decreased adipose tissue inflammation. The beneficial effect of calpain inhibition was asso-
ciated with the reduction of macrophage accumulation and inflammation, which attributed to blunted functional 
properties of macrophage migration. Furthermore, calpain inhibition significantly modulated adipose tissue 
remodeling by influencing fibrosis and adipocyte apoptosis. This is the first report to document the functional 
role of calpain in adipose tissue remodeling during obesity.
In the present study, HFD-induced obesity in mice profoundly increased adipose tissue calpain protein and 
activity. CAST overexpression significantly suppressed HFD-induced calpain activity, as evidenced by the sup-
pressed breakdown of fluorescent labeled calpain substrate. This result is consistent with our recently published 
and other earlier studies showing that CAST overexpression sufficiently suppressed high fat and AngII-induced 
calpain activity in various tissues16,29. Using a diet-induced obesity model, our current study revealed that CAST 
overexpression-mediated calpain inhibition had no effect on the development of obesity and did not affect food 
intake. Consistent with this current observation, several recent pathological studies from our group and others 
examined calpain function in mice fed high cholesterol or fat enriched diets and showed calpain deficiency or 
inhibition had no effect on body weight in mice18,19,29,39. However, in a recent study, administration of BDA-410, 
a non-selective calpain inhibitor, to chow fed 23-month old sedentary female mice induced loss of body weight 
and fat mass40. The loss in body weight was mainly due to muscle wasting and lipolysis40. The difference in body 
weight change between this published study and our current observation could be explained by the following 
factors: (i) Age - 10 weeks vs 23 months. (ii) The diet model - the HFD-induced body weight gain is more robust 
than chow diet. In addition, in our current study, calpain inhibition had no effect on body weight gain under 
either LFD or HFD condition. It appears that calpain inhibition may promote lipolysis under chow fed diet con-
dition, whereas it had no effect on HFD-induced fat accumulation. (iii) The another important factor is sex. The 
BDA-410 study used only aged females whereas our current study is on males. It is not clear whether calpain plays 
a diverse role in male and female in regulating lipolysis and body weight gain. Further studies are required using 
both male and female genders side by side under 2 different diets (LFD and HFD) to examine whether the age and 
sex play a critical role in calpain mediated body weight regulation under different diet conditions.
Furthermore, GTT and ITT studies indicated that HFD feeding exacerbated obesity associated insulin resist-
ance. Interestingly, CAST overexpression showed a slight and significant improvement in the early stage (5 weeks) 
of obesity, which disappeared in the late stage of obesity (16 weeks). At 5 weeks of diet-induced obesity, fasting 
plasma insulin concentration was significantly higher in HFD-CAST Tg mice compared to HFD-WT and LFD 
fed mice. At 16 weeks of diet-induced obesity, plasma insulin concentration was significantly higher in both 
HFD- WT and Tg mice (Figure SIII in the online-only Data Supplement). However, the magnitude of increase 
was significantly higher in Tg group compared to WT group. Interestingly, irrespective of greater insulin con-
centration, CAST Tg group showed no significant improvement on GTT compared to WT group. CAST is well 
known to inhibit both calpain-1 and -2 activity41. Calpain-10, a member of atypical calpains, is shown to be 
associated with type 2 diabetes and insulin resistance due to a variation in the calpain-10 gene in type 2 diabe-
tes population with a single nucleotide polymorphisms at a rare allele SNP 4420,21. Calpain-10 lacks a penta-EF 
hand in domain IV of its catalytic subunit and are unable to bind to the CAST2,42. Our western blot studies using 
calpain-10 antibodies ruled out that there is no alteration in calpain-10 protein in EPiWAT of HFD-fed CAST Tg 
mice either at 5 or 16 weeks (Figure SIIIE,F in the online-only Data Supplement).
Interestingly, our qPCR analyses of liver tissue from 5 and 16 weeks LFD and HFD groups showed a strong 
suppression of PCK-1 gene in CAST Tg mice fed with LFD for 5 and 16 weeks. In the case of HFD feeding, CAST 
Tg overexpression showed a significant suppression of hepatic PCK-1 at 5 weeks, whereas the effect disappeared 
post 16 weeks HFD feeding. Suppression of PCK-1 in liver is shown to promote insulin sensitivity in obese mice37. 
Consistently, the GTT studies showed a significant improvement in glucose clearance in CAST Tg mice fed with 
HFD for 5 weeks. In addition, CAST Tg overexpression showed a significant improvement in glucose clearance 
in LFD fed mice post 16 weeks, whereas the beneficial effect of CAST Tg overexpression disappeared upon HFD 
feeding. In consistent, the PCK-1 mRNA expression was comparable between WT and Tg groups post 16 HFD 
feeding. In addition, the CAST Tg overexpression had no beneficial effect on GTT post 16 weeks. These data 
clearly indicate that CAST Tg mediated calpain inhibition transiently suppresses hepatic PCK-1, which in turn 
promotes insulin sensitivity in the early stage of obesity. Further studies are warranted to understand the mecha-
nisms by which (i) calpain activation promotes PCK-1 gene expression and activity and (ii) CAST overexpression 
leads to insulin resistance in long term obesity.
Adipocyte cell death has been proposed as a key mechanism that leads to macrophage infiltration into adipose 
tissue during the development of obesity24,25. In support, genetic inactivation of pro-apoptotic gene, Bid in mice 
prevented adipocyte death and adipose tissue macrophage infiltration26. Calpains are shown to play a critical 
role in calcium mediated cell apoptosis in association with caspase-3 pathway in various cell types22,23. In con-
sistent, we observed increased adipocyte death as evidenced by increased TUNEL positive nuclei and increased 
cleaved caspase activity in HFD-induced mice. CAST Tg overexpression mediated calpain inhibition significantly 
suppressed obesity induced apoptotic cell death, pro-apoptotic genes (Bid, Bax, and Bcl10), and adipose tis-
sue macrophage accumulation. With respect to adipose tissue macrophage accumulation, CAST overexpression 
had no influence on adipose tissue MCP-1 secretion, a major monocyte chemoattractant protein. In contrast, 
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CAST overexpression impaired macrophage migration property towards MCP-1, which may have contributed to 
decreased macrophage accumulation in adipose tissue. In support, in our very recent published study, we showed 
that CAST overexpression in macrophages suppressed AngII-induced macrophage migration and adhesion to 
endothelial cells in vitro29. In the present study, calpain inhibition reduced obesity-induced pro-inflammatory 
gene expression including TNFα, IL-6, and IL-1β in adipose tissue. In addition, calpain silencing in differentiated 
adipocytes suppressed LPS-induced NF-kB activation (P65 phosphorylation) and prevented LPS-induced IkB 
degradation. IKK-dependent NF-kB activation has been implicated in the development of obesity and adipose 
tissue inflammation30,43. NF-kB translocation inhibitor, IκB, was also shown to be a target of calpain in selected 
cell types including macrophages17,32–34. In support, CAST deficiency in intestinal macrophages also induced 
NF-kB translocation to the nucleus17. Furthermore, deletion of calpain-4, the common small subunit of calpain-1 
and -2 in cardiomyocytes resulted in suppressed NF-kB activity followed myocardial infarction in mice12. NF-kB 
activation plays an important role in promoting expression of various proinflammatory factors (e.g. MCP-1, 
IL-6), which mediate inflammatory responses44,45. The observed reduction in adipocyte apoptosis, in addition 
to, impaired macrophage migration, and accumulation upon CAST overexpression may well correlate with the 
observed reduction of obesity-induced adipose tissue inflammation.
Overproduction of extracellular matrix components in adipose tissue has been implicated in systemic insu-
lin resistance and hepatic steatosis in obese mice and humans35,46,47. In the present study, CAST overexpression 
strongly suppressed the induction of various collagen genes which are well known to play a critical role in the 
production of matrix components in adipose tissue. Recently, accumulated macrophages are also shown to play 
an important role in the regulation of adipose tissue fibrosis48. Consistent with these reports, we observed a strong 
reduction in macrophage accumulation in CAST overexpressing mice, which in turn may contribute to suppres-
sion of collagen gene induction in Tg mice adipose tissue. However, future studies are required to understand the 
mechanisms through which calpain regulates functional properties of macrophages in regulating matrix produc-
tion and subsequent fibrosis.
In summary, we demonstrated that inhibition of calpain results in decreased obesity-induced adipose tissue 
inflammation, which is associated with reduced adipocyte apoptosis and fibrosis. These results suggest that inhibi-
tion of calpain activity may offer a new therapeutic target to reduce obesity-induced adipose tissue inflammation.
Methods
Mice. Mice overexpressing calpastatin (CAST-Tg) driven by a cytomegalovirus promoter on a C57BL/6 
background were generated originally in the laboratory of Dr. Laurent Baud49. CAST-Tg mice were backcrossed 
at least 9 generations into a C57BL/6 background. C57BL/6 J (Stock# 000664) mice were purchased from The 
Jackson Laboratory (Bar Harbor, ME). Age-matched controls (8–10 weeks old) were used for the present study. 
Mice were maintained in a barrier facility. All study procedures were approved by the University of Kentucky 
Institutional Animal Care and Use Committee (Protocol # 2011–0907). This study followed the recommendations 
of The Guide for the Care and Use of Laboratory Animals (National Institutes of Health).
Mouse Genotyping. Mouse genotypes were confirmed by PCR. DNA was isolated from tail snips 
or BM-derived cells using a Maxwell tissue DNA kit (Cat# AS1030, Promega, Madison, WI). CAST-Tg 
genotyping was performed using the following primers: 5′-GTTGGCTTAGGCTGCTTTTCGT-3′ and 
5′-CCAGACTCCGTGA CACCCCTT-3′. The resultant CAST-Tg PCR product was 518 base pairs (bp) and no 
product for non-transgenic mice. The IL-2 gene was used as an internal control for CAST-Tg genotyping using the 
following primers: 5′-CTAGGCCACAGAATTGAAAGATCT and 5′-GTAGGTGGAAATTCTAGCATCATCC. 
The resultant product was 324 bp (Figure SI in the online-only Data Supplement).
Diet. Mice were fed a low fat diet (LFD, 10% kcal as fat; D12450B; Research Diets Inc, New Brunswick, NJ) 
or high fat diet (HFD, 60% kcal as fat; D12492, Research Diets Inc, New Brunswick, NJ) for 5 or 16 weeks. Mice 
were provided water and diet ad libitum. At study endpoint, mice were anesthetized with a mixture of ketamine/
xylazine (100/10 mg/kg, i.p) for exsanguination and tissue harvest. Blood was collected in tubes containing EDTA 
(0.2 mol/L), centrifuged at 2,000 rpm for 20 min (4 °C) and plasma was stored at -80 °C. Tissues were snap frozen 
in liquid nitrogen and stored at −80 °C.
Metabolic and Histological Analyses. Body weight was measured weekly. At baseline and study end-
points, fat and lean mass were measured on conscious mice using NMR spectroscopy (Echo MRI). Intraperitoneal 
glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed after 5 weeks or 15 weeks of LFD or 
HFD feeding. Mice were fasted either for 6 h (GTT) or 4 h (ITT) before intraperitoneal injections of glucose (2 g/
kg body weight) or insulin (0.5 unit/kg body weight; Novolin R, Novo Nordisk Inc.). Blood glucose concentra-
tions were measured using a glucometer at 0, 15, 30, 45, 60 and 120 minutes post injection. Histological, immu-
nohistochemical and immunofluorescent staining of adipose tissue sections were performed on formalin-fixed 
sections, with appropriate negative controls, as described previously50,51. Immunohistochemical staining was per-
formed on adipose sections to detect calpain, F4/80 positive macrophages and active caspase-3 protein. Calpain-2 
immunostaining was performed using the rabbit anti-mouse calpain-2 (10 µg/ml, catalog No. RP-2 Calpain-2; 
Triple Point biologics, Forest Grove, OR). The F4/80 and active caspase-3 staining were performed using the 
following antibodies: rat anti-mouse F4/80 (1:200, catalog No. ab6640; Serotec, Abcam, Cambridge, MA) for 
macrophages; and rabbit anti-mouse cleaved caspase-3 (2 µg/ml, catalog No: 9661; Cell Signaling, Beverly, MA) 
for active caspase-3. TUNEL staining for adipose tissue sections was performed using the IN Situ Cell Death 
Detection Kit (Roche Applied Science).
Adipocyte Size Analyses. Hematoxylin and eosin stained EpiWAT sections were imaged at 10x magni-
fication and the size of adipocytes were quantified as described previously52. Briefly, using the measurement 
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features of NIS Elements software including detection of edges, image thresholding, and object counting, the area 
and number of adipocytes within a 700 × 700 µm measurement frame were quantified. Adipocyte numbers were 
quantified on three measurement frames within each section of EpiWAT (n = 5 mice in each group).
Measurement of Blood and Plasma Components. Peripheral blood cell numbers were counted using 
a Hemavet 950 (Drew Scientific Inc, Dallas, TX). Plasma insulin, leptin and adiponectin concentrations were 
measured using commercially available ELISA kits (R&D systems) as described previously50.
Macrophage Migration Assay. Migration assays were performed using transwells with 8.0-μm pore 
polycarbonate membrane inserts (Corning)53. Bone marrow cells were harvested from the femurs of WT and 
CAST-Tg mice54 and differentiated into bone marrow-derived macrophages (BMDMs) using RPMI media con-
taining 10% FBS and 15% L929 Cells (mouse fibroblast) conditioned medium for 7 days29. The fresh media was 
provided every 48 h. On day 7, WT and CAST-Tg BMDMs were trypsinized, counted, and seeded (1 × 106 in a 
volume of 50 μl media/well) on transwell filters, and lower chambers were filled with either control media or media 
containing MCP-1 (100 ng/mL). After a 6 h incubation at 37 °C, cells were removed from the upper surface of 
inserts by scraping with Q-Tips. The membranes were fixed with 1% glutaraldehyde (Sigma; catalog No: G5882), 
stained with hematoxylin (Leica) and mounted on glass slides using glycerol gelatin. Hematoxylin-stained cells 
were counted using a microscope (Nikon, Melville, NY) by two independent investigators in a blinded man-
ner. An example of the membrane stained with hematoxylin is shown in the supplement information (Figure 
SVIII in the online-only Data Supplement). Only the cells that migrated through the pores in response to MCP-1 
are stained with hematoxylin. The non-hematoxylin stained circles are not cells, but rather transwell membrane 
pores. The hematoxylin stained cells were counted from 9 fields at the power of 200x magnification and quantified 
(n = 4).
Quantification of MCP-1 Release from Adipose Tissue Explants by ELISA. Adipose tissue explants 
(epididymal fat, 50 mg) harvested from WT and CAST-Tg mice were incubated with vehicle or adipogenic cock-
tail (100 nM insulin, 1 µM dexamethasone, 0.5 mM IBMX) for 24 h in a 12 well plate. Culture media from tissue 
explants were collected and centrifuged at 13,000 rpm for 5 minutes. Supernatants were stored at −80 °C until 
assay. Accumulation of MCP-1 protein in media was measured with a mouse MCP-1 ELISA kit (R & D System; 
catalog No: MJE00) and normalized to tissue explant protein.
3T3-L1 Cell Differentiation and Short Interfering RNA Knockdown. 3T3-L1 cells were first differen-
tiated into mature adipocytes as described previously55. Differentiated 3T3-L1 cells were transfected with control 
short interfering (si)RNA or siRNA targeting the mouse calpain-4 (the common small subunit of calpain-1 and -2; 
Ambion - Silencer Select validated siRNA, Thermo Fisher Scientific) sequences using RNAiMax lipofectamine 
transfection reagent (Life Technologies, Thermo Fisher Scientific). After 48 h of transfection, cells were treated 
with vehicle or LPS (100ng/ml) for 24 h for western blot analyses.
mRNA Abundance. Total RNA was extracted from adipose tissue or cells using the SV Total RNA Isolation 
System (Promega; catalog No: Z3100). RNA (100 ng) was reverse transcribed using the iScript cDNA synthesis kit 
(Cat #170–8891; Bio-Rad, Hercules, CA). Quantitative PCR was performed to quantify mRNA abundance using 
a SsoFas EvaGreen Supermix kit (Cat # 172–5203; Bio-Rad) on a Bio-Rad CFX96 cycler. mRNA abundances 
were calculated by normalization to internal control 18 S rRNA. Non-template and no RT reactions were used as 
negative controls. The primers used are detailed in Supplementary Table 2.
Western Blot Analyses. Cell or tissue lysates were extracted in radio immunoprecipitation assay lysis buffer 
and protein content was measured using a Bradford assay (Bio-Rad, Hercules, CA). Protein extracts (20–30 μg) 
were resolved by SDS-PAGE (6.0 or 7.5% wt/vol) and transferred electrophoretically to PVDF membranes 
(Millipore). After blocking with non-dry fat milk (5% wt/vol), membranes were probed with primary antibodies. 
The following antibodies were used: calpain-1 domain IV (Abcam, catalog No: ab39170), calpain-2 (Abcam, 
catalog No: ab39165), calpain-4 (Triple Point Biologics, catalog No: RP3 Calpain-4) calpain-10 (Triple Point 
Biologics, catalog No: RP1 Calpain-10), calpastatin (Cell Signaling, catalog No. 4146), NF-kB phospho P-65 (Ser 
536) (Cell Signaling, catalog No:3033 P), total P-65 (Cell Signaling, catalog No:8242 P), IKBα (Cell Signaling, 
catalog No:4814 P) and β-actin (Sigma-Aldrich, catalog No: A5441). Membranes were incubated with appropriate 
HRP-labeled secondary antibodies. Immune complexes were visualized by chemiluminescence (Pierce, Rockford, 
IL) and quantified using a Kodak Imager.
Statistical Analyses. Data are represented as mean ± SEM. Statistical analyses were performed using 
SigmaPlot 12.0 (SYSTAT Software Inc., San Jose, CA, USA). Student′s t test or Mann-Whitney Rank Sum test was 
performed as appropriate for two-group comparisons. One or Two way ANOVA with Holm-Sidak post hoc anal-
ysis were performed for multiple-group and multiple-manipulation analysis. Values of P < 0.05 were considered 
to be statistically significant.
Data Availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author upon reasonable request.
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